{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:44:24Z","timestamp":1792899864977,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1124\/jpet.123.001791","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T17:10:14Z","timestamp":1700241014000},"page":"145-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction"],"prefix":"10.1016","volume":"388","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9181-3741","authenticated-orcid":false,"given":"Berna","family":"G\u00fcven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory S.","family":"Wagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Almeida de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaya L.","family":"Persad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Onay-Besikci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin Y.","family":"Oudit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary D.","family":"Lopaschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.123.001791_bib1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/HYPERTENSIONAHA.113.02043","article-title":"Negative impact of \u03b2-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms","volume":"63","author":"Bathgate-Siryk","year":"2014","journal-title":"Hypertension"},{"key":"10.1124\/jpet.123.001791_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10741-014-9453-8","article-title":"Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis","volume":"20","author":"Bavishi","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1124\/jpet.123.001791_bib3","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bbalip.2007.04.018","article-title":"Modulation of PPAR activity via phosphorylation","volume":"1771","author":"Burns","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.123.001791_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","article-title":"Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials","volume":"39","author":"Cleland","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.123.001791_bib5","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1124\/jpet.123.001791_bib6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/CIRCULATIONAHA.106.662296","article-title":"Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-\u03b1\/PGC-1\u03b1 gene regulatory pathway","volume":"115","author":"Duncan","year":"2007","journal-title":"Circulation"},{"key":"10.1124\/jpet.123.001791_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.amjcard.2009.09.008","article-title":"Effect of Beta-blocker therapy on rehospitalization rates in women versus men with heart failure and preserved ejection fraction","volume":"105","author":"Farasat","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1124\/jpet.123.001791_bib8","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.bbalip.2016.03.020","article-title":"Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes","volume":"1861","author":"Fukushima","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.123.001791_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/ijcp.12567","article-title":"Beta-blocker therapy and prognosis of heart failure patients with new-onset diabetes mellitus","volume":"69","author":"Garcia-Egido","year":"2015","journal-title":"Int J Clin Pract"},{"key":"10.1124\/jpet.123.001791_bib10","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1111\/bph.15269","article-title":"Metabolic effects of carvedilol through \u03b2-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts","volume":"177","author":"G\u00fcven","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001791_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jacc.2008.09.031","article-title":"Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry","volume":"53","author":"Hernandez","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.123.001791_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00004872-199604000-00012","article-title":"Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study","volume":"14","author":"Jacob","year":"1996","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.123.001791_bib13","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/dom.13762","article-title":"Weight loss enhances cardiac energy metabolism and function in heart failure associated with obesity","volume":"21","author":"Karwi","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/jpet.123.001791_bib14","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.amjmed.2018.07.008","article-title":"Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate","volume":"131","author":"Lam","year":"2018","journal-title":"Am J Med"},{"key":"10.1124\/jpet.123.001791_bib15","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1113\/jphysiol.2012.230185","article-title":"Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects","volume":"590","author":"Larsen","year":"2012","journal-title":"J Physiol"},{"key":"10.1124\/jpet.123.001791_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/08037059209077499","article-title":"Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients","volume":"1","author":"Lithell","year":"1992","journal-title":"Blood Press"},{"key":"10.1124\/jpet.123.001791_bib17","article-title":"Effects of beta-blockers on heart failure with preserved ejection fraction: a meta-analysis","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.001791_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yjmcc.2021.12.015","article-title":"Mitochondrial protein hyperacetylation underpins heart failure with preserved ejection fraction in mice","volume":"165","author":"Liu","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/jpet.123.001791_bib19","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nature07617","article-title":"Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance","volume":"457","author":"Luan","year":"2009","journal-title":"Nature"},{"key":"10.1124\/jpet.123.001791_bib20","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.2014.15241","article-title":"Association between use of \u03b2-blockers and outcomes in patients with heart failure and preserved ejection fraction","volume":"312","author":"Lund","year":"2014","journal-title":"JAMA"},{"key":"10.1124\/jpet.123.001791_bib21","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.123.001791_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224674","article-title":"Carvedilol improves glucose tolerance and insulin sensitivity in treatment of adrenergic overdrive in high fat diet-induced obesity in mice","volume":"14","author":"Nguyen","year":"2019","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.001791_bib23","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1139\/y2012-015","article-title":"Carvedilol suppresses fatty acid oxidation and stimulates glycolysis in C2C12 cells","volume":"90","author":"Onay-Besikci","year":"2012","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/jpet.123.001791_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.123.001791_bib25","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1136\/bmj.298.6681.1152","article-title":"Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients","volume":"298","author":"Pollare","year":"1989","journal-title":"BMJ"},{"key":"10.1124\/jpet.123.001791_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature03354","article-title":"Nutrient control of glucose homeostasis through a complex of PGC-1\u03b1 and SIRT1","volume":"434","author":"Rodgers","year":"2005","journal-title":"Nature"},{"key":"10.1124\/jpet.123.001791_bib27","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/CIRCRESAHA.122.320257","article-title":"Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models","volume":"130","author":"Roh","year":"2022","journal-title":"Circ Res"},{"key":"10.1124\/jpet.123.001791_bib28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijcard.2016.07.292","article-title":"Prognosis of heart failure with preserved ejection fraction treated with \u03b2-blockers: A propensity matched study in the community","volume":"222","author":"Ruiz","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1124\/jpet.123.001791_bib29","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2337\/db14-1050","article-title":"Lowering body weight in obese mice with diastolic heart failure improves cardiac insulin sensitivity and function: implications for the obesity paradox","volume":"64","author":"Sankaralingam","year":"2015","journal-title":"Diabetes"},{"key":"10.1124\/jpet.123.001791_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"key":"10.1124\/jpet.123.001791_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175126","article-title":"Colchicine alleviates inflammation and improves diastolic dysfunction in heart failure rats with preserved ejection fraction","volume":"929","author":"Shen","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.123.001791_bib32","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"JCS 2017\/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure\u3000- Digest Version","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"10.1124\/jpet.123.001791_bib33","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/MCB.20.5.1868-1876.2000","article-title":"The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor \u03b1 in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes","volume":"20","author":"Vega","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.123.001791_bib34","doi-asserted-by":"crossref","first-page":"16657","DOI":"10.1073\/pnas.0707936104","article-title":"A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling","volume":"104","author":"Wisler","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.123.001791_bib35","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/cvr\/cvaa256","article-title":"The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction","volume":"117","author":"Withaar","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.123.001791_bib36","article-title":"The progress and controversial of the use of beta blockers in patients with heart failure with a preserved ejection fraction","volume":"26","author":"Xu","year":"2019","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1124\/jpet.123.001791_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/eurjhf\/hfs141","article-title":"Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)","volume":"15","author":"Yamamoto","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1124\/jpet.123.001791_bib38","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCHEARTFAILURE.112.000228","article-title":"Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy","volume":"6","author":"Zhang","year":"2013","journal-title":"Circ Heart Fail"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.001791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:32:52Z","timestamp":1739971972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524171455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0022356524171455"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.001791","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.001791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}